Clinical Trials

20 enrolled

Gastroesophageal Adenocarcinoma

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT06346197 2026-03-02

CIME

132 enrolled

Phase EARLY_PHASE1 Recruiting

Neoplasm Metastasis, Stomach Neoplasms

NCT07193862 2026-02-27

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

10 enrolled

Colorectal Cancer Metastatic

NCT07309289 2025-12-30

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

144 enrolled

Colorectal Neoplasms

NCT06154538 2025-11-28

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

170 enrolled

Locally Advanced Colorectal Carcinoma

NCT06846346 2025-11-28

GRACIE

88 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT06529718 2025-11-17

SEVILLA

72 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT04656041 2025-11-14

Folfox+Irinotecan+Chemort In Esophageal Cancer

Gastroesophageal Junction Adenocarcinoma

NCT07204574 2025-10-02

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

Phase 1/2 Recruiting

CRC

NCT07192185 2025-09-25

Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab

30 enrolled

Carcinoma, Hepatocellular

NCT06253611 2025-09-22

BIG

120 enrolled

Stomach Neoplasms

NCT05024097 2025-08-27

PANTHER

43 enrolled

Rectal Neoplasms

NCT06719362 2025-07-10

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

110 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06893887 2025-07-02

ICT-HCC

Phase NA Recruiting

300 enrolled

Carcinoma, Hepatocellular

NCT06991465 2025-05-28

Hypo-OPRA

35 enrolled

Colorectal Neoplasms

NCT06907342 2025-05-25

COSENSE-1

148 enrolled

Colorectal Neoplasms

NCT05303714 2025-02-21

PIPAC_VEROne

98 enrolled

Oligometastatic Gastric Adenocarcinoma

NCT06833866 2025-02-19

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

33 enrolled

Colorectal Neoplasms

NCT06831981 2025-02-18

ARO 2024-13

Phase NA Recruiting

264 enrolled

Hyperthermia, Rectal Neoplasms

NCT06475352 2025-01-27

FUDOSE

400 enrolled

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

NCT05462613 2024-12-20

REPROGRAM-02

Phase 2/3 Recruiting

446 enrolled

Colorectal Neoplasms

NCT05534087 2024-11-29

CLAUDIA

236 enrolled

Colonic Neoplasms, Neoplasm, Residual

NCT04516681 2024-10-24

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

400 enrolled

Colorectal Neoplasms

NCT05476796 2024-10-24

LOGICAN

118 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT05124002 2024-03-04

Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

Phase 4 Recruiting

66 enrolled

Cholangiocarcinoma

NCT05912075 2024-02-08

PRAAR1

78 enrolled

Locally-advanced Rectal Cancer

NCT06218810 2024-01-23

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

53 enrolled

Colorectal Neoplasms

NCT05815082 2023-04-18

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

490 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT05797077 2023-04-04

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

346 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms, Neoplasms, Second Primary

NCT05718492 2023-02-08

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Phase NA Recruiting

100 enrolled

Carcinoma, Hepatocellular

NCT05476432 2022-12-09

HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

300 enrolled

Carcinoma, Hepatocellular

NCT04389086 2022-09-06

PelvEx II

364 enrolled

Margins of Excision, Rectal Neoplasms

NCT05194878 2022-01-18

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

840 enrolled

Colonic Neoplasms

NCT03985891 2020-12-17

JSFOL

Phase 1/2 Recruiting

Colonic Neoplasms

NCT03925662 2019-04-24

Mebendazole as Adjuvant Treatment for Colon Cancer